Alberta to fund new cystic fibrosis drug

Alberta is among the first provinces and territories in Canada to provide access to the new cystic fibrosis drug Trikafta.

Trikafta is used to treat the most common form of cystic fibrosis, which affects about 90 per cent of those living with the disease. The medication is approved for those 12 years and older who meet eligibility criteria.

READ MORE HERE